Biotechnology Entrepreneur Incentives Marketing 
Harvard Business Review
MARCH 17, 2014
An estimated 250 funds are actively raising capital in a market that the Global Impact Investing Network estimates at $25 billion. These entrepreneurs are looking for support from risk-seeking investors who have an appetite for failure, are willing to be pioneers, and who value the social returns they’re creating.
Harvard Business Review
OCTOBER 26, 2011
Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.
Expert insights. Personalized for you.
8 
Let's personalize your content